Home›Companies›Biotech & Pharma›Linus Biotechnology

Linus Biotechnology Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 12, 2024·Suggest an edit

About Linus Biotechnology

Linus Biotechnology is a private company based in North Brunswick, New Jersey, incorporated in 2020 in Delaware. It has reported $31,646,629 raised in three offerings on Form D since March 2022. Its chief executive is Manish Arora.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 29, 2024Aug 12, 2024$6,149,995of $9.9M target4$1.5MEquityRule 506(b)Form D ↗
May 19, 2023May 26, 2023$7,999,997fully sold3$2.6MEquityRule 506(b)Form D ↗
Mar 11, 2022Mar 22, 2022$17,496,637fully sold14$1.2MEquityRule 506(b)Form D ↗
Total, three offerings$31,646,629

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Linus Biotechnology's Form D filed Aug 12, 2024.

RS
Rafi Syed
Director
AD
MA
Manish Arora
Chief Executive Officer and director

Earlier filings also listed Jan Glassner (cfo and director, last listed Mar 2022).

Sources

  1. SECLinus Biotechnology Inc. filing history